Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition

BMC Biotechnology

Florence Rouleux-Bonnin¹  Chantal Pichon³  Patrick Midoux³  Gwenhael Jégot²  David Gosset³  Solenne Bire⁴ 

[1]LNOX, GICC UMR CNRS 7292, UFR de Médecine, Bâtiment Dutrochet, 10 Boulevard Tonnellé, Tours 37000, France

[2]Equipe BIOS, Unité PRC, INRA, Nouzilly 37380, France

[3]CBM-UPR CNRS, 4301 - Rue Charles Sadron Cedex 2, Orléans 45071, France

[4]LBTM, Institute of Biotechnology, UNIL-EPFL, Station 6, Lausanne 1015, Switzerland

关键词: Bioavailability;    Transposition;    PiggyBac;    Gene delivery;    mRNA trafficking;   

Others  :  1089647
DOI  :  10.1186/1472-6750-13-75

 received in 2013-03-19, accepted in 2013-09-12,  发布年份 2013

【 摘 要 】

Background

Up to now, the different uptake pathways and the subsequent intracellular trafficking of plasmid DNA have been largely explored. By contrast, the mode of internalization and the intracellular routing of an exogenous mRNA in transfected cells are poorly investigated and remain to be elucidated. The bioavailability of internalized mRNA depends on its intracellular routing and its potential accumulation in dynamic sorting sites for storage: stress granules and processing bodies. This question is of particular significance when a secure transposon-based system able to integrate a therapeutic transgene into the genome is used. Transposon vectors usually require two components: a plasmid DNA, carrying the gene of interest, and a source of transposase allowing the integration of the transgene. The principal drawback is the lasting presence of the transposase, which could remobilize the transgene once it has been inserted. Our study focused on the pharmacokinetics of the transposition process mediated by the piggyBac transposase mRNA transfection. Exogenous mRNA internalization and trafficking were investigated towards a better apprehension and fine control of the piggyBac transposase bioavailability.

Results

The mRNA prototype designed in this study provides a very narrow expression window of transposase, which allows high efficiency transposition with no cytotoxicity. Our data reveal that exogenous transposase mRNA enters cells by clathrin and caveolae-mediated endocytosis, before finishing in late endosomes 3 h after transfection. At this point, the mRNA is dissociated from its carrier and localized in stress granules, but not in cytoplasmic processing bodies. Some weaker signals have been observed in stress granules at 18 h and 48 h without causing prolonged production of the transposase. So, we designed an mRNA that is efficiently translated with a peak of transposase production 18 h post-transfection without additional release of the molecule. This confines the integration of the transgene in a very small time window.

Conclusion

Our results shed light on processes of exogenous mRNA trafficking, which are crucial to estimate the mRNA bioavailability, and increase the biosafety of transgene integration mediated by transposition. This approach provides a new way for limiting the transgene copy in the genome and their remobilization by mRNA engineering and trafficking.

【 授权许可】

   
2013 Bire et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Bire S, Rouleux-Bonnin F: Transposable elements as tools for reshaping the genome: it is a huge world after all! Methods Mol Biol 2012, 859:1-28.
• [2]Wilson M, Coates C, George A: PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 2007, 15:139-145.
• [3]Wu S, Meir Y, Coates C, Handler A, Pelczar A, Moisyadi S, Kaminski J: piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci USA 2006, 103:15008-15013.
• [4]Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M: PiggyBac transposon-mediated long-term gene expression in mice. Mol Ther 2010, 18:707-714.
• [5]Bire S, Rouleux-Bonnin F: Transgene site specific integration: problems and solutions. In Topics in Current Genetics, Volume 23. Edited by Renault S, Duchateau P. Netherlands: Springer; 2013:3-39.
• [6]Palazzoli F, Bire S, Bigot Y, Bonnin-Rouleux F: Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction. Nat Biotechnol 2011, 29:593-597.
• [7]Shinmyo Y, Mito T, Matsushita T, Sarashina L, Miyawaki K, Ohuchi H, Noji S: PiggyBac-mediated somatic transformation of the two-spotted cricket, Gryllus bimaculatus. Dev Growth Differ 2004, 46:343-349.
• [8]Morales M, Mann V, Kines K, Gobert G, Fraser M, Kalinna B, Correnti J, Pearce E, Brindley P: PiggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni. FASEB J 2007, 21:3479-3489.
• [9]Furushima K, Jang CW, Chen DW, Xiao N, Overbeek PA, Behringer RR: Insertional mutagenesis by a hybrid PiggyBac and sleeping beauty transposon in the Rat. Genetics 2012, 192:1235-1248.
• [10]Wilber A, Frandsen J, Geurts J, Largaespada D, Hackett P, McIvor R: RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Mol Ther 2006, 3:625-630.
• [11]Al-Dosari MS, Gao X: Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 2009, 11:671-681.
• [12]Bettinger T, Carlisle R, Read M, Ogris M, Seymour L: Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res 2001, 29:3882-3891.
• [13]Mockey M, Gonçalves C, Dupuy F, Lemoine F, Pichon C, Midoux P: mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level. Biochem Biophys Res Commun 2006, 340:1062-1068.
• [14]Bieber T, Meissner W, Kostin S, Niemann A, Elsasser H: Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J Control Release 2002, 82:441-454.
• [15]Rejman J, Bragonzi A, Conese M: Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther 2005, 12:468-474.
• [16]Midoux P, Breuzard G, Gomez JP, Pichon C: Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Curr Gene Ther 2008, 8:335-352.
• [17]Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler M, Scheuner D, Kaufman R, Golan D, Anderson P: Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 2005, 169:871-884.
• [18]Anderson P, Kedersha N: Stress granules: the Tao of RNA triage. Trends Biochem Sci 2008, 33:141-150.
• [19]Elango N, Elango S, Shivshankar P, Katz M: Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector. Biochem Biophys Res Commun 2005, 330:958-966.
• [20]Rejman J, Tavernier G, Bavarsad N, Demeester J, De Smedt SC: mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. J Control Release 2010, 147:385-391.
• [21]Debus H, Baumhof P, Probst J, Kissel T: Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: biophysical characterization and in vitro transfection properties. J Control Release 2010, 148:334-343.
• [22]Grosse S, Aron Y, Thévenot G, François D, Monsigny M, Fajac I: Potocytosis and cellular exit of complexes as cellular pathways for gene delivery by polycations. J Gene Med 2005, 7:1275-1286.
• [23]Hillaireau H, Couvreur P: Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66:2873-2896.
• [24]Lorenz C, Fotin-Mleczek M, Roth G, Becker C, Dam TC, Verdurmen WP, Brock R, Probst J, Schlake T: Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway. RNA Biol 2011, 8:627-636.
• [25]Diken M, Kreiter S, Selmi A, Britten CM, Huber C, Türeci Ö, Sahin U: Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation. Gene Ther 2011, 18:702-708.
• [26]Rejman J, Oberle V, Zuhorn I, Hoekstra D: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169.
• [27]Akinc A, Thomas M, Klibanov AM, Langer R: Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005, 7:657-663.
• [28]Kedersha N, Anderson P: Mammalian stress granules and processing bodies. Methods Enzymol 2007, 431:61-81.
• [29]Anderson P, Kedersha K: Stressful initiations. J Cell Sci 2002, 115:3227-3234.
• [30]Brengues M, Teixeira M, Parker R: Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 2005, 310:486-489.
• [31]Mollet S, Cougot N, Wilczynska A, Dautry F, Kress M, Bertrand E, Weil D: Translationally repressed mRNA transiently cycles through stress granules during stress. Mol Biol Cell 2008, 19:4469-4479.
• [32]Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Türeci O, Sahin U: Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 2006, 108:4009-4017.
• [33]Cadiñanos J, Bradley A: Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res 2007, 35:e87.